• Something wrong with this record ?

Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats

E. Dolezelova, A. Prasnicka, J. Cermanova, A. Carazo, L. Hyrsova, M. Hroch, J. Mokry, M. Adamcova, A. Mrkvicova, P. Pavek, S. Micuda,

. 2017 ; 23 (43) : 7678-7692.

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc18033486

AIM: To investigate the effect of resveratrol on biliary secretion of cholephilic compounds in healthy and bile duct-obstructed rats. METHODS: Resveratrol (RSV) or saline were administered to rats by daily oral gavage for 28 d after sham operation or reversible bile duct obstruction (BDO). Bile was collected 24 h after the last gavage during an intravenous bolus dose of the Mdr1/Mrp2 substrate azithromycin. Bile acids, glutathione and azithromycin were measured in bile to quantify their level of biliary secretion. Liver expression of enzymes and transporters relevant for bile production and biliary secretion of major bile constituents and drugs were analyzed at the mRNA and protein levels using qRT-PCR and Western blot analysis, respectively. The TR-FRET PXR Competitive Binding Assay kit was used to determine the agonism of RSV at the pregnane X receptor. RESULTS: RSV increased bile flow in sham-operated rats due to increased biliary secretion of bile acids (BA) and glutathione. This effect was accompanied by the induction of the hepatic rate-limiting transporters for bile acids and glutathione, Bsep and Mrp2, respectively. RSV also induced Cyp7a1, an enzyme that is crucial for bile acid synthesis; Mrp4, a transporter important for BA secretion from hepatocytes to blood; and Mdr1, the major apical transporter for xenobiotics. The findings were supported by increased biliary secretion of azithromycin. The TR-FRET PXR competitive binding assay confirmed RSV as a weak agonist of the human nuclear receptor PXR, which is a transcriptional regulator of Mdr1/Mrp2. RSV demonstrated significant hepatoprotective properties against BDO-induced cirrhosis. RSV also reduced bile flow in BDO rats without any corresponding change in the levels of the transporters and enzymes involved in RSV-mediated hepatoprotection. CONCLUSION: Resveratrol administration for 28 d has a distinct effect on bile flow and biliary secretion of cholephilic compounds in healthy and bile duct-obstructed rats.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18033486
003      
CZ-PrNML
005      
20181012110751.0
007      
ta
008      
181008s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.3748/wjg.v23.i43.7678 $2 doi
035    __
$a (PubMed)29209109
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Dolezelova, Eva $u Department of Biological and Medical Sciences, Charles University, Faculty of Pharmacy in Hradec Kralove, 50003 Hradec Kralove, Czech Republic.
245    10
$a Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats / $c E. Dolezelova, A. Prasnicka, J. Cermanova, A. Carazo, L. Hyrsova, M. Hroch, J. Mokry, M. Adamcova, A. Mrkvicova, P. Pavek, S. Micuda,
520    9_
$a AIM: To investigate the effect of resveratrol on biliary secretion of cholephilic compounds in healthy and bile duct-obstructed rats. METHODS: Resveratrol (RSV) or saline were administered to rats by daily oral gavage for 28 d after sham operation or reversible bile duct obstruction (BDO). Bile was collected 24 h after the last gavage during an intravenous bolus dose of the Mdr1/Mrp2 substrate azithromycin. Bile acids, glutathione and azithromycin were measured in bile to quantify their level of biliary secretion. Liver expression of enzymes and transporters relevant for bile production and biliary secretion of major bile constituents and drugs were analyzed at the mRNA and protein levels using qRT-PCR and Western blot analysis, respectively. The TR-FRET PXR Competitive Binding Assay kit was used to determine the agonism of RSV at the pregnane X receptor. RESULTS: RSV increased bile flow in sham-operated rats due to increased biliary secretion of bile acids (BA) and glutathione. This effect was accompanied by the induction of the hepatic rate-limiting transporters for bile acids and glutathione, Bsep and Mrp2, respectively. RSV also induced Cyp7a1, an enzyme that is crucial for bile acid synthesis; Mrp4, a transporter important for BA secretion from hepatocytes to blood; and Mdr1, the major apical transporter for xenobiotics. The findings were supported by increased biliary secretion of azithromycin. The TR-FRET PXR competitive binding assay confirmed RSV as a weak agonist of the human nuclear receptor PXR, which is a transcriptional regulator of Mdr1/Mrp2. RSV demonstrated significant hepatoprotective properties against BDO-induced cirrhosis. RSV also reduced bile flow in BDO rats without any corresponding change in the levels of the transporters and enzymes involved in RSV-mediated hepatoprotection. CONCLUSION: Resveratrol administration for 28 d has a distinct effect on bile flow and biliary secretion of cholephilic compounds in healthy and bile duct-obstructed rats.
650    _2
$a ABC transportéry $x metabolismus $7 D018528
650    _2
$a aplikace orální $7 D000284
650    _2
$a zvířata $7 D000818
650    _2
$a antiflogistika nesteroidní $x farmakologie $x terapeutické užití $7 D000894
650    _2
$a antioxidancia $x farmakologie $x terapeutické užití $7 D000975
650    _2
$a azithromycin $x farmakokinetika $7 D017963
650    _2
$a žlučové kyseliny a soli $x chemie $x sekrece $7 D001647
650    _2
$a cholestáza $x farmakoterapie $x etiologie $x patofyziologie $7 D002779
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a glutathion $x sekrece $7 D005978
650    _2
$a hepatocyty $x účinky léků $x metabolismus $x sekrece $7 D022781
650    _2
$a lidé $7 D006801
650    _2
$a játra $x účinky léků $x metabolismus $x patofyziologie $7 D008099
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a steroidní receptory $x agonisté $7 D011987
650    _2
$a stilbeny $x farmakologie $x terapeutické užití $7 D013267
655    _2
$a časopisecké články $7 D016428
700    1_
$a Prasnicka, Alena $u Department of Pharmacology, Charles University, Faculty of Medicine in Hradec Kralove, 50003 Hradec Kralove, Czech Republic.
700    1_
$a Cermanova, Jolana $u Department of Pharmacology, Charles University, Faculty of Medicine in Hradec Kralove, 50003 Hradec Kralove, Czech Republic.
700    1_
$a Carazo, Alejandro $u Department of Pharmacology and Toxicology, Charles University, Faculty of Pharmacy in Hradec Kralove, 50003 Hradec Kralove, Czech Republic.
700    1_
$a Hyrsova, Lucie $u Department of Pharmacology and Toxicology, Charles University, Faculty of Pharmacy in Hradec Kralove, 50003 Hradec Kralove, Czech Republic.
700    1_
$a Hroch, Milos $u Department of Medical Biochemistry, Charles University, Faculty of Medicine in Hradec Kralove, 50003 Hradec Kralove, Czech Republic.
700    1_
$a Mokry, Jaroslav $u Department of Histology and Embryology, Charles University, Faculty of Medicine in Hradec Kralove, 50003 Hradec Kralove, Czech Republic.
700    1_
$a Adamcova, Michaela $u Department of Physiology, Charles University, Faculty of Medicine in Hradec Kralove, 50003 Hradec Kralove, Czech Republic.
700    1_
$a Mrkvicova, Alena $u Department of Medical Biochemistry, Charles University, Faculty of Medicine in Hradec Kralove, 50003 Hradec Kralove, Czech Republic.
700    1_
$a Pavek, Petr $u Department of Pharmacology and Toxicology, Charles University, Faculty of Pharmacy in Hradec Kralove, 50003 Hradec Kralove, Czech Republic.
700    1_
$a Micuda, Stanislav $u Department of Pharmacology, Charles University, Faculty of Medicine in Hradec Kralove, 50003 Hradec Kralove, Czech Republic. micuda@lfhk.cuni.cz.
773    0_
$w MED00006918 $t World journal of gastroenterology $x 2219-2840 $g Roč. 23, č. 43 (2017), s. 7678-7692
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29209109 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20181012111243 $b ABA008
999    __
$a ok $b bmc $g 1340925 $s 1030480
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 23 $c 43 $d 7678-7692 $i 2219-2840 $m World journal of gastroenterology $n World J Gastroenterol $x MED00006918
LZP    __
$a Pubmed-20181008

Find record

Citation metrics

Archiving options